AQST

AQST Financing Cash Flow

$83.90MTTM · USD

Period ending:

AQST FY Cash from FinancingUSD
AQST FY Cash from Financing2016-12-31: $5.69M2017-12-31: $4.41M2018-12-31: $58.04M2019-12-31: $49.60M2020-12-31: $28.46M2021-12-31: $30.11M2022-12-31: $11.56M2023-12-31: $3.97M2024-12-31: $83.59M2025-12-31: $102.62M$102.62M$0.00
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AQST financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Aquestive Therapeutics Inc Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
102,617,000
83,592,000
3,974,000
11,562,000
30,109,000
28,457,000
49,600,000
58,035,000
4,414,000
5,689,000

Compare financing cash flow

All AQST financial metrics · AQST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.